These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28922069)

  • 41. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased Fear Memory and Glutamatergic Modulation in Compulsive Drinker Rats Selected by Schedule-Induced Polydipsia.
    Prados-Pardo Á; Martín-González E; Mora S; Merchán A; Flores P; Moreno M
    Front Behav Neurosci; 2019; 13():100. PubMed ID: 31133835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Glutamatergic conception of mood disorders].
    Permoda-Osip A; Rybakowski J
    Psychiatr Pol; 2011; 45(6):875-88. PubMed ID: 22335130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overlapping dimensional phenotypes of impulsivity and compulsivity explain co-occurrence of addictive and related behaviors.
    Tiego J; Oostermeijer S; Prochazkova L; Parkes L; Dawson A; Youssef G; Oldenhof E; Carter A; Segrave RA; Fontenelle LF; Yücel M
    CNS Spectr; 2019 Aug; 24(4):426-440. PubMed ID: 30458896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Otasowie J; Castells X; Ehimare UP; Smith CH
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD006997. PubMed ID: 25238582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Memantine: a review of possible uses in child and adolescent psychiatry.
    Hosenbocus S; Chahal R
    J Can Acad Child Adolesc Psychiatry; 2013 May; 22(2):166-71. PubMed ID: 23667364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systematic review and meta-analysis: Memantine augmentation in moderate to severe obsessive-compulsive disorder.
    Modarresi A; Chaibakhsh S; Koulaeinejad N; Koupaei SR
    Psychiatry Res; 2019 Dec; 282():112602. PubMed ID: 31630042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frontostriatal functional connectivity correlates with repetitive behaviour across autism spectrum disorder and obsessive-compulsive disorder.
    Akkermans SEA; Rheinheimer N; Bruchhage MMK; Durston S; Brandeis D; Banaschewski T; Boecker-Schlier R; Wolf I; Williams SCR; Buitelaar JK; van Rooij D; Oldehinkel M;
    Psychol Med; 2019 Oct; 49(13):2247-2255. PubMed ID: 30362446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glutamatergic dysfunction in skin-picking disorder: treatment of a pediatric patient with N-acetylcysteine.
    Percinel I; Yazici KU
    J Clin Psychopharmacol; 2014 Dec; 34(6):772-4. PubMed ID: 25203471
    [No Abstract]   [Full Text] [Related]  

  • 50. Atomoxetine for attention deficit hyperactivity disorder in children and adolescents with autism: A systematic review and meta-analysis.
    Patra S; Nebhinani N; Viswanathan A; Kirubakaran R
    Autism Res; 2019 Apr; 12(4):542-552. PubMed ID: 30653855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impulsivity and compulsive buying are associated in a non-clinical sample: an evidence for the compulsivity-impulsivity continuum?
    Paula JJ; Costa Dde S; Oliveira F; Alves JO; Passos LR; Malloy-Diniz LF
    Braz J Psychiatry; 2015; 37(3):242-4. PubMed ID: 26376055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of memantine in adult patients with attention deficit hyperactivity disorder.
    Mohammadzadeh S; Ahangari TK; Yousefi F
    Hum Psychopharmacol; 2019 Jan; 34(1):e2687. PubMed ID: 30663824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial.
    Farnia V; Gharehbaghi H; Alikhani M; Almasi A; Golshani S; Tatari F; Davarinejad O; Salemi S; Sadeghi Bahmani D; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2018 Sep; 104():137-143. PubMed ID: 30044966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain imaging in pediatric obsessive-compulsive disorder.
    MacMaster FP; O'Neill J; Rosenberg DR
    J Am Acad Child Adolesc Psychiatry; 2008 Nov; 47(11):1262-72. PubMed ID: 18827717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.
    Parsons CG; Stöffler A; Danysz W
    Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
    Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J
    J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder.
    Rosa-Neto P; Lou HC; Cumming P; Pryds O; Karrebaek H; Lunding J; Gjedde A
    Neuroimage; 2005 Apr; 25(3):868-76. PubMed ID: 15808987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
    Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
    Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glutamatergic modulators: the future of treating mood disorders?
    Zarate C; Machado-Vieira R; Henter I; Ibrahim L; Diazgranados N; Salvadore G
    Harv Rev Psychiatry; 2010; 18(5):293-303. PubMed ID: 20825266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Compulsivity in obsessive-compulsive disorder and addictions.
    Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D
    Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.